Crossref
hsa-miR-9 and drug control over the P38 network as driving disease outcome in GBM patients
Systems Biomedicine · 2013
DOI: 10.4161/sysb.25815 ↗At a glance
Journal article in Systems Biomedicine, 2013. Written by Rotem Ben-Hamo and 1 co-authors. 32 references.
Abstract (original language)
Ebda abstract disponibbli.
Cite
APA
Ben-Hamo, R., & Efroni, S. (2013). hsa-miR-9 and drug control over the P38 network as driving disease outcome in GBM patients. Systems Biomedicine. https://doi.org/10.4161/sysb.25815
Vancouver
Ben-Hamo R, Efroni S. hsa-miR-9 and drug control over the P38 network as driving disease outcome in GBM patients. Systems Biomedicine. 2013. doi:10.4161/sysb.25815
BibTeX
@article{BenHamo2013,
author = {Ben-Hamo, Rotem and Efroni, Sol},
title = {hsa-miR-9 and drug control over the P38 network as driving disease outcome in GBM patients},
journal = {Systems Biomedicine},
year = {2013},
doi = {10.4161/sysb.25815}
}
EUVIMED